Dan Ollendorf

Sarepta: Enough, For God's Sake

Sarepta: Enough, For God's Sake | Science | AAAS share.google/WcxLae5lKrqy...

It was very engaging, Jason! Really enjoyed everyone's take.

YouTube video by Boston University School of Public Health Vaccine Hesitancy: Past, Present, and Future

Great conversation on vaccine hesitancy (and all things US vaccine policy) hosted by the folks at @busph.bsky.social yesterday. Here’s the recording www.youtube.com/watch?v=FSCw...

Health Economics Methods Advisory Group Releases Draft Report: Assessing Treatment Benefits in HTA Decision-Making tinyurl.com/yc47dejv

This Shutdown Fight Has Life-or-Death Consequences At the heart of the fight over the government shutdown is the fate of health insurance for millions of Americans who may soon face an impossible choice: accept a significant increase in their premiums...

4.2 million people may lose coverage if Congress doesn't extend premium subsidies for ACA plans.

“These are your friends, neighbors, and colleagues who [will] lose insurance, and their health [will] suffer as a result.”— @rachelwerner.bsky.social in @bloomberg.com.
www.bloomberg.com/opinion/arti...

Was great fun to write this with Sarah Emond! A value-based approach could be used to reduce traditional access barriers and possibly mitigate back-end legislative remedies...

Val and I checked repeatedly because we simply couldn't believe no national or local news organizations covered this letter from 18 AGs in support of trans youth care and against FTC overreach.

If you find any stories, let us know, but it seems to be our exclusive.

Institute for Clinical and Economic Review to Assess Vaccines for COVID-19: tinyurl.com/2tfn5pme

I was back at 26 Federal Plaza today, where an ICE agent violently threw this bereft woman to the ground in front of her kids. She had not touched him. She did not pose any threat. She had to be taken to the hospital. (🎥: Elias Eliahu)

There's one typo, referring to the combo vaccine as "MMRW"...

A new paper led by Harvard Health Policy PhD student Ye Shen finds that, in the current policy environment, more than six in ten kids will have been enrolled in Medicaid for some period of time by their 18th birthday; the program is absolutley critical for children.

jamanetwork.com/journals/jam...

Suzanne Swierc Let me be clear: if you think Charlie Kirk was a wonderful person, we can't be friends. His death is a tragedy, and I can and do feel for his wife and children. I believe in the Resurrection, and while it's difficult, I can and do pray for his soul. Charlie Kirk's death is a reflection of the violence, fear, and hatred he sowed. It does not excuse his death, AND it's a sad truth. The shooting is a tragedy, and I can and do feel for a college campus experiencing an active shooter situation. The deaths of Melissa and Mark Hortman, the children shot and killed in Minneapolis last month, and the children shot in Colorado today are all tragedies that also deserve your attention. Charlie Kirk excused the deaths of children in the name of the second amendment.

Here’s what a Ball State University employee said that led to their termination:

Make your voice heard -- your opportunity to comment coming up! @htaiorg.bsky.social @cda-amc.bsky.social @nicecomms.bsky.social

The Health Economics Methods Advisory (HEMA) has a new website! hemamethods.org

HEMA was convened by leaders at 3 global HTA organizations: ICER, @nicecomms.bsky.social, and @cda-amc.bsky.social
to critically and independently examine and assess new methods and processes.

The first HEMA Draft Report will be published on September 24th, which will be open to public comment until October 15th.

Mark your calendars and submit your public comments via public_comments@hemamethods.org!

Learn more: hemamethods.org

Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...

New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...

@icer-review.bsky.social @tuftscevr.bsky.social @peterneumann11.bsky.social @pattysynnott.bsky.social

Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...

New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...

A Cancer Patient Chose Assisted Death. That Wasn’t the Last Hard Choice.

#RIP to a kind, intelligent, and thoughtful researcher and evidence advocate. But as you can see from this @nytimes.com piece, also a true leader to the end:

www.nytimes.com/2025/08/03/h...

VUMC researchers host international fellows for economic evaluation, decision science training Vanderbilt recently hosted 11 international fellows to provide training to help them address public health issues in their home countries.

Great application of our CEA Registry at the #Vanderbilt Center for Health Economic Modeling: 11 international fellows from #LMICs used the Registry to conduct CEAs of public health interventions.

Read more at: tinyurl.com/88varaue

@peterneumann11.bsky.social #ISPOR

Health Economics and Outcomes Research (HEOR) Certificate Program - Tufts CTSI Overview The Tufts University Graduate School of Biomedical Sciences (GSBS) Clinical and Translational Science (CTS) Graduate Program is delighted to offer an accredited Certificate Program in Health ...

Two weeks left to apply: Earn your #HEOR Certificate online from @tufts.edu with globally-recognized faculty like @peterneumann11.bsky.social, @dano-hta.bsky.social, James Chambers, and more from CEVR. Apply today!

Deadline is Aug. 1.

tinyurl.com/pr6drkhf

#RWE #pharma

The Medsky feed is close to 200 likes, so if you can please support by liking, sharing, and pinning it!

I know this sounds silly but the more engagement the feed receives the more likely it is that people will see there’s a dedicated space on Bluesky to discuss and share healthcare information.

Importantly, much work still to be done to explore the applicability of available frameworks and integration into #HTA processes. I look forward to the work ahead.

Frontiers | Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability Combination therapies are a mainstay in cancer treatment, but reimbursement access can be limited, owing to complexities around value assessment and pricing,...

Traditional #valueassessment lacks methods to evaluate #oncology combination txs, posing challenges for drugmakers, HTA bodies, and payers.

In a new commentary in Frontiers in Pharmacology, CEVR’s Dan Ollendorf et al explore available frameworks and chart a path forward: tinyurl.com/kh84ueb4

Pleased to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, supported by the Gordon and Betty Moore Foundation.

cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social

Celebrating Ten Years of the international Decision Support Initiative Over the last decade, iDSI has partnered with countries to develop evidence-informed priority-setting institutions and processes. Read our blog for a summary of key successes, challenges, and lessons ...

Excited to contribute to a special issue of @BMJ_EBM, offering timely analysis on India’s experience of institutionalizing health technology assessment, with lessons for other LMICs.
Read on to see an adaptation of a @icer-review.bsky.social HTA report for the Indian context! ⬇
bit.ly/4h2UGGC

CTAF June 2025 Public Meeting on Secondary Progressive Multiple Sclerosis

This Friday -- at 12 PM ET join us for the virtual public meeting on the comparative clinical effectiveness and value of tolebrutinib (made by Sanofi) for the treatment of secondary progressive multiple sclerosis.

Register here: shorturl.at/razPI #heor #hta

FDA's AI tool, Elsa, is here. 'The stupidest big fuss they ever made' This is the web edition of STAT's AI Prognosis, our subscriber-exclusive newsletter.

The FDA's AI, Elsa, can't even tell you who the FDA leadership is.

Despite being updated thru April 2024, Elsa exclusively listed leaders who have left the FDA, including 3 that retired in 2022-23 and one that left in '21.

More on Elsa (& which version of Claude it uses), only at AI Prognosis: 🖥️🩺

We're excited to announce Tufts-CEVR's new partnership with ISPOR to provide free, premium access to the CEA Registry for ISPOR members who are students or researchers in LMICs.

More detail here: cevr.tuftsmedicalcenter.org/news/cevr-is...

@djvanness.bsky.social @tuftscevr.bsky.social

Screenshot of MMWR alert email, where the “in case you missed it” section features a 2024 study quantifying the health and economic benefits of routine childhood immunization since 1994.

CDC staff are still fighting the good fight with all available tools — including today’s MMWR email alert.